secwatch.observer — SEC 8-K summary
======================================

Issuer:     FORUM MARKETS Inc (FRMM)
CIK:        0001690080
Form:       8-K
Filed at:   2023-09-07T23:59:59+00:00
Accession:  0001213900-23-074568
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 3.03, 5.02, 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

180 Life Sciences amends bylaws; grants stock options to CEO, CSO, CFO
----------------------------------------------------------------------

- Reduced stockholder meeting quorum to one-third of voting power via new Second Amended and Restated Bylaws effective Sept 4, 2023.
- Approved incentive stock options for CEO James Woody (75k shares), CSO Jonathan Rothbard (15k), CFO Ozan Pamir (15k) at $0.67/share, vesting monthly over 12 months.
- Options granted under First Amended and Restated 2022 Omnibus Incentive Plan, with 10-year term.
- Bylaws also updated for SEC Rule 14a-19 proxy rules and exclusive means for stockholder proposals.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1690080/000121390023074568/0001213900-23-074568-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1690080/000121390023074568/ea184802-8k_180life.htm
  HTML page:      https://secwatch.observer/filing/0001213900-23-074568

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer